115 related articles for article (PubMed ID: 1196345)
1. Letter: Ornithine or citrulline therapy in treatment of Reye's syndrome.
Tremblay GC
N Engl J Med; 1975 Jan; 292(3):160-1. PubMed ID: 1196345
[No Abstract] [Full Text] [Related]
2. Letter: Citrulline for Reye's syndrome.
DeLong GR; Glick TH; Shannon DC
N Engl J Med; 1974 Jun; 290(26):1488. PubMed ID: 4831769
[No Abstract] [Full Text] [Related]
3. Letter: Citrulline for Reye's syndrome.
N Engl J Med; 1974 Aug; 291(8):421. PubMed ID: 4855508
[No Abstract] [Full Text] [Related]
4. The use of citrulline for the treatment of Reye's syndrome: case reports.
Oetgen WJ
Mil Med; 1977 Feb; 142(2):162-4. PubMed ID: 401969
[No Abstract] [Full Text] [Related]
5. [Reye's syndrome: pathogenetic problems (author's transl)].
Sabetta G; Castro M; Donfrancesco A; Castelli P; Lucidi V; Lubrano R; Ruberto U; Qaddourah M
Pediatr Med Chir; 1981; 3(6):555-7. PubMed ID: 7343954
[TBL] [Abstract][Full Text] [Related]
6. Citrulline in Reye's syndrome.
Thisyakorn U; Sunakorn P
J Med Assoc Thai; 1980 Apr; 63(4):196-9. PubMed ID: 7381355
[No Abstract] [Full Text] [Related]
7. Pathogenesis of Reye's syndrome: A working hypothesis.
Thaler MM
Pediatrics; 1975 Dec; 56(6):1081-4. PubMed ID: 1196760
[No Abstract] [Full Text] [Related]
8. Potential hazard of therapy for Reye's syndrome with urea cycle intermediates.
Glasgow AM
Pediatrics; 1977 Oct; 60(4):557-8. PubMed ID: 905032
[No Abstract] [Full Text] [Related]
9. Transiently reduced activity of carbamyl phosphate synthetase and ornithine transcarbamylase in liver of children with Reye's syndrome.
Brown T; Hug G; Lansky L; Bove K; Scheve A; Ryan M; Brown H; Schubert WK; Partin JC; Lloyd-Still J
N Engl J Med; 1976 Apr; 294(16):861-7. PubMed ID: 175276
[TBL] [Abstract][Full Text] [Related]
10. Letter: Reye's syndrome.
Thaler MM; Hoogenraad NJ
Lancet; 1975 Dec; 2(7945):1154. PubMed ID: 53646
[No Abstract] [Full Text] [Related]
11. Letter: Role of ornithine transcarbamylase in Reye's syndrome.
Thaler MM
N Engl J Med; 1974 Oct; 291(15):797. PubMed ID: 4414380
[No Abstract] [Full Text] [Related]
12. Letter: Reye's syndrome and the kinetics of ornithine carbamoyltransferase.
Lee AR; Balinsky JB; Rossouw JE
Lancet; 1975 Sep; 2(7935):606. PubMed ID: 51430
[No Abstract] [Full Text] [Related]
13. Letter: Carbamyl phosphate synthetase and ornithine transcarbamylase in liver of Reye's syndrome.
Brown T; Brown H; Lansky L; Hug G
N Engl J Med; 1974 Oct; 291(15):797-8. PubMed ID: 4414133
[No Abstract] [Full Text] [Related]
14. Encephalopathy of Reye's syndrome: a review of pathogenetic hypotheses.
DeLong GR; Glick TH
Pediatrics; 1982 Jan; 69(1):53-63. PubMed ID: 7033913
[TBL] [Abstract][Full Text] [Related]
15. Letter: Reye's syndrome.
Brown T; Hug G; Bove K; Brown H; Lansky L
Lancet; 1974 Sep; 2(7882):716-7. PubMed ID: 4142983
[No Abstract] [Full Text] [Related]
16. [Coagulation analysis in Reye's syndrome].
Jacobi H; Altemeier KH; Künzer W
Monatsschr Kinderheilkd (1902); 1975 Jul; 123(7):573-4. PubMed ID: 1152854
[No Abstract] [Full Text] [Related]
17. Letter: Reye's syndrome.
Lancet; 1974 Nov; 2(7890):1203. PubMed ID: 4139610
[No Abstract] [Full Text] [Related]
18. [New data on Reye's syndrome].
Grabowska-Lubaszko U; Ejsmont L; Bukowska W
Pol Tyg Lek; 1975 Nov; 30(46):1915-7. PubMed ID: 1197064
[No Abstract] [Full Text] [Related]
19. Therapy of Reye's syndrome.
Haller JS
Am J Hosp Pharm; 1979 Dec; 36(12):1654, 1657-8. PubMed ID: 525639
[No Abstract] [Full Text] [Related]
20. Resveratrol protects against experimental induced Reye's syndrome by prohibition of oxidative stress and restoration of complex I activity.
Abdin A; Sarhan N
Can J Physiol Pharmacol; 2014 Sep; 92(9):780-8. PubMed ID: 25162205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
